Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) reported $1.22 earnings per share for the quarter, meeting the analysts’ consensus estimate of $1.22. The company had revenue of $5.00 billion for the quarter, compared to the consensus estimate of $5.11 million. During the same quarter last year, the company posted $1.12 earnings per share. Teva Pharmaceutical Industries Ltd’s revenue was up 2.0% compared to the same quarter last year. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) net profit margin is 6.80% and weekly performance is 2.28%. On last trading day company shares ended up $51.98. Analysts mean target price for the company is $55.91. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) distance from 50-day simple moving average (SMA50) is 2.80%.
On 10 JUNE Novo Nordisk A/S (ADR) (NYSE:NVO) said it initiated a share repurchase programme in accordance with the provisions of the European Commission’s regulation no 2273/2003. Novo Nordisk A/S (ADR) (NYSE:NVO) shares fell -0.25% in last trading session and ended the day on $44.42. NVO Gross Margin is 83.30% and its return on assets is 38.60%. Novo Nordisk A/S (ADR) (NYSE:NVO) quarterly performance is -1.68%.
On 10 JUNE Pharmacyclics, Inc. (NASDAQ:PCYC) announced that the U.S. Food and Drug Administration has agreed to file its supplemental New Drug Application in support of the review of its drug IMBRUVICA for the treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma for complete approval. The supplemental NDA is useful in the therapy of patients who have received at least one treatment previously. Pharmacyclics, Inc. (NASDAQ:PCYC) shares moved down -1.22% in last trading session and was closed at $95.49, while trading in range of $95.04 – $99.48. Pharmacyclics, Inc. (NASDAQ:PCYC) year to date (YTD) performance is -9.26%.
On 10 JUNE Lannett Company, Inc. (NYSE:LCI) reported significant earnings per share improvement in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past two years. Lannett Company, Inc. (NYSE:LCI) ended the last trading day at $48.41. Company weekly volatility is calculated as 3.43% and price to cash ratio as 13.94. Lannett Company, Inc. (NYSE:LCI) showed a positive weekly performance of 7.03%.
On 4 JUNE POZEN Inc. (NASDAQ:POZN) reported that its annual Total Revenue rose from $5.35 million in 2012 to $10.32 million in 2013 while its respective Net Loss increased from $25.28 million to $16.71 million. Shares of POZEN Inc. (NASDAQ:POZN) grew from $2.51 per share in November 2011 to as high as $9.77 per share in late 2013. POZEN Inc. (NASDAQ:POZN) net profit margin is -49.10% and weekly performance is 8.01%. On last trading day company shares ended up $9.30. Analysts mean target price for the company is $9.00. POZEN Inc. (NASDAQ:POZN) distance from 50-day simple moving average (SMA50) is 9.10%.
Leave a Reply